Fair Value Calculator Fair Value Calculator
EN DE

SWISSMLTRY (SWISSMLTRY) Fair Value & Analysis

IN · Market cap ₹3.8B

S SWISSMLTRY SWISSMLTRY · BSE
Price₹16.05
Fair Value₹5.67
Upside-64.7%
Quality48/100
Watch SWISSMLTRY for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹4.23 – ₹7.10

Fair value as of: Jul 6, 2026

From 16 valuation models · updated today

Share price −4.0% over the past month.

Price vs Fair Value (12 months)

₹28.70 ₹13.02 Fair Value ₹5.67 Jun 2025 Jul 2026

12‑month range ₹13.02 – ₹28.70 · fair‑value band ₹4.23 – ₹7.10 · the ₹16.05 price screens above the ₹5.67 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SWISSMLTRY (SWISSMLTRY) currently trades at ₹16.05, while our model-based Fair Value estimate is ₹5.67 — implying the stock looks roughly 64.7% overvalued today. We read business quality at 48/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SWISSMLTRY generated revenue of ₹2.6B at a net margin of 2.9%. Revenue grew 9.0% year over year. It earns a return on equity of 5.7%. Net debt stands at ₹15.0M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹4.23 (bear case) to ₹7.10 (bull case); at ₹16.05, the current price sits above that range. The share trades about 44% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.6B
Revenue growth (YoY) +9.0%
Net margin 2.9%
Return on equity 5.7%
Free cash flow −₹6.5M FY2026
P/E ratio 50.2
More key figures
Operating margin 3.1%
EPS (TTM) ₹0.3200
EPS growth (YoY) -50.0%
Net debt ₹15.0M FY2022

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SWISSMLTRY reported revenue of ₹2.6B in FY2026 versus ₹555M in FY2022, a compound +47.1%/yr. Reported net income was ₹75.6M in FY2026, compounding +28.8%/yr from FY2022.

Revenue +47.1%/yr
FY22 ₹555M
FY23 ₹1.3B
FY24 ₹1.9B
FY25 ₹2.2B
FY26 ₹2.6B
Net income +28.8%/yr
FY22 ₹27.5M
FY23 ₹61.8M
FY24 ₹83.5M
FY25 ₹87.7M
FY26 ₹75.6M

Is SWISSMLTRY fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SWISSMLTRY Fair Value". https://www.fairvalue-calculator.com/stock/SWISSMLTRY

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SWISSMLTRY (SWISSMLTRY) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹5.67 versus a price of ₹16.05 — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SWISSMLTRY?
Our model-based fair value for SWISSMLTRY is ₹5.67 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹16.05.
What is the quality score of SWISSMLTRY?
SWISSMLTRY has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SWISSMLTRY (SWISSMLTRY)?
SWISSMLTRY reported trailing-twelve-month revenue of about ₹2.6B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SWISSMLTRY?
The net profit margin of SWISSMLTRY is about 2.9%, meaning it keeps roughly 2.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.